在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

COL1A1 Monoclonal Antibody

  • 中文名稱:
    COL1A1鼠單克隆抗體
  • 貨號:
    CSB-MA317506
  • 規(guī)格:
    ¥1090
  • 圖片:
    • Immunohistochemical analysis of paraffin-embedded Human Colon Carcinoma Tissue using Collagen I Mouse mAb diluted at 1:200.
    • Immunohistochemical analysis of paraffin-embedded Human skin Carcinoma Tissue using Collagen I Mouse mAb diluted at 1:200.
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    CUSABIO貨號:CSB-MA317506 COL1A1單克隆抗體是一款靶向I型膠原蛋白α1鏈的高特異性科研試劑,適用于人、小鼠及大鼠樣本的ELISA和免疫組化(IHC)檢測。作為細胞外基質(zhì)核心成分,COL1A1在組織纖維化、創(chuàng)傷修復及腫瘤微環(huán)境調(diào)控中發(fā)揮關鍵作用,其異常表達與肝纖維化、肺纖維化及骨代謝疾病等病理過程密切相關。本產(chǎn)品采用雜交瘤技術制備,具有嚴格的種屬交叉反應驗證,可精準識別天然構象的COL1A1蛋白,特別適用于骨基質(zhì)形成研究、皮膚纖維化模型分析以及腫瘤微環(huán)境中膠原沉積的動態(tài)觀察。在應用場景上,該抗體可支持體外ELISA定量檢測細胞培養(yǎng)上清或組織裂解液中的COL1A1含量,同時滿足石蠟包埋組織的IHC染色需求,為心血管疾病機制研究、再生醫(yī)學領域的膠原重塑分析提供可靠工具。其穩(wěn)定的批間一致性及廣泛的模型適用性,使之成為結締組織病理研究、抗纖維化藥物開發(fā)等科研項目的優(yōu)選試劑。
  • Uniprot No.:
  • 基因名:
  • 別名:
    Alpha 1 type I collagen antibody; Alpha 2 type I collagen antibody; alpha 2 type I procollagen antibody; alpha 2(I) procollagen antibody; alpha 2(I)-collagen antibody; Alpha-1 type I collagen antibody; alpha1(I) procollagen antibody; CO1A1_HUMAN antibody; COL1A1 antibody; COL1A2 antibody; collagen alpha 1 chain type I antibody; Collagen alpha-1(I) chain antibody; collagen alpha-1(I) chain preproprotein antibody; Collagen I alpha 1 polypeptide antibody; Collagen I alpha 2 polypeptide antibody; collagen of skin; tendon and bone; alpha-1 chain antibody; collagen of skin; tendon and bone; alpha-2 chain antibody; Collagen type I alpha 1 antibody; Collagen type I alpha 2 antibody; EDSC antibody; OI1 antibody; OI2 antibody; OI3 antibody; OI4 antibody; pro-alpha-1 collagen type 1 antibody; type I proalpha 1 antibody; type I procollagen alpha 1 chain antibody; Type I procollagen antibody
  • 宿主:
    Mouse
  • 反應種屬:
    Human,Mouse,Rat
  • 免疫原:
    Synthetic Peptide of Collagen I
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated
  • 純化方式:
    The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
  • 克隆號:
    30E10
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
  • 產(chǎn)品提供形式:
    Liquid
  • 應用范圍:
    ELISA,IHC
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:50-1:200
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

  • 功能:
    Type I collagen is a member of group I collagen (fibrillar forming collagen).
  • 基因功能參考文獻:
    1. results strengthen the evidence for the association between polymorphisms of -1997 G/T, +1245 G/T of the COL1A1 gene in the genetic etiology of keloid scars PMID: 27511505
    2. Structural basis of homo- and heterotrimerization of COL1A1/ COL1A2 has been reported. PMID: 28281531
    3. patients with OI have homogenously thinner corneas compared with controls, we observed that a collagen I chain mutation was not responsible for corneal curvature alterations in OI. PMID: 30272615
    4. Our findings demonstrate that collagen I could enhance the aggressive progression of residual hepatocellular carcinoma cells after suboptimal heat treatment and sorafenib may be a treatment approach to thwart this process. PMID: 30227844
    5. Cellular expression of COL1A1 could promote breast cancer metastasis. COL1A1 is a new prognostic biomarker and a potential therapeutic target for breast cancer, especially in ER+ patients. PMID: 29906404
    6. miR-129-5p level was decreased in fibrotic liver of human, and reduced by rOPN treatment. In contrast, miR-129-5p was induced in HSCs transfected by OPN siRNA. These data suggested that OPN induces Col 1 expression via suppression of miR-129-5p in hepatic stellate cells. PMID: 29196165
    7. Depletion of MRTF-A abolished the upregulation of COL1A1 in response to the TGF-beta or Wnt signaling. PMID: 29807221
    8. Mutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III. PMID: 29543922
    9. DNMT1 was downregulated in the Lung Cancer group and its expression was further reduced in the presence of increasing malignant burden as indicated by the endobronchial findings further suggesting an Lung Cancer-specific signature. PMID: 29568927
    10. our results indicated that COL1A1 promotes tumor metastasis, and that its inhibition may suppress CRC cell migration. In addition, the role of COL1A1 in CRC metastasis seems to be associated with the regulation of the WNT/PCP pathway. PMID: 29393423
    11. miR378b represses the mRNA expression levels of COL1A1 via interference with SIRT6 in human dermal fibroblasts. PMID: 28983623
    12. Exogenous proline stimulates type I collagen and HIF-1alpha expression and the process is attenuated by glutamine in human skin fibroblasts. PMID: 28526934
    13. the efficacy of pamidronate treatment does not seem to be related to the genotype of type I collagen in patients with osteogenesis imperfecta. PMID: 28528406
    14. High urine collagen is associated with renal dysfunction in lupus nephritis. PMID: 28339802
    15. MiR-133a-3p could inhibit the proliferation and migration of oral squamous cell carcinoma cells through directly targeting COL1A1 and reducing its expression. PMID: 28569392
    16. COL1A1 gene mutation is associated with osteogenesis imperfecta. PMID: 28810924
    17. Elevation of serum alpha1(I) collagen DNA levels in scleroderma patients may be useful as the diagnostic marker, reflecting the presence of vasculopathy. PMID: 28370352
    18. study showed that GG homozygotes were underrepresented in the ACL-rupture group compared with the control group, which suggests an association with reduced risk of anterior cruciate ligament injury PMID: 27632864
    19. Review/Meta-analysis: possible relationship between GG genotype of COL1A1 +1245G/T polymorphism and osteoporosis risk in post-menopausal women. PMID: 28261929
    20. These results support an activation mechanism of DDR1 whereby collagen induces lateral association of DDR1 dimers and phosphorylation between dimers. PMID: 28590245
    21. This study identified collagen gene sets related to self-reported depression scores in healthy participants. PMID: 28334615
    22. an endoplasmic reticulum complex of resident chaperones that includes HSP47, FKBP65, and BiP regulating the activity of LH2. PMID: 28177155
    23. Although serum procollagen type-1 N-terminal propeptide (PINP) levels were not found to be different, tartrate-resistant acid phosphatase type 5b isoform (TRACP 5b) levels were significantly higher in the control group. PMID: 27840329
    24. mutations of the COL1A1 and COL1A2 genes probably underlie the disease in the four families PMID: 28981938
    25. Our results indicated that COL1A1 rs1800012 polymorphism may be associated with the reduced risk of sports-related tendon or ligament injuries, especially in ACL injuries, and that rare TT may played as a protective role. PMID: 28206959
    26. Significance was detected for GG homozygous carriers (P=0.043); this genotype might be a risk factor for this type of low-density lesion (odds ratio 1.643, 95% confidence interval 1.016-2.658). PMID: 27371342
    27. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions. PMID: 27503584
    28. COL1a1 crystal structure of fibronectin type III domain shows an immunoglobulin-like fold containing a beta-sandwich structure, which is formed by a three-stranded beta-sheet. PMID: 29199991
    29. Alterations in the extracellular matrix microenvironment, particularly type I collagen, likely contributes to bladder cancer progression. PMID: 27655672
    30. Strong correlations between the expression of type I, II, IV collagen and osteopontin and the clinical stage of tympanosclerosis indicate the involvement of these proteins in excessive fibrosis and pathological remodeling of the tympanic membrane. PMID: 29068597
    31. The results support the association of COL1A1 gene polymorphisms with fracture and with low BMD at the hip in Mexican population PMID: 26423565
    32. urinary N-telopeptide measured in early postmenopause is most strongly associated with rates of bone loss across the menopause transition. PMID: 27322414
    33. Abnormal regulation of COL1 and COL3 may contribute to the early predisposition to POP in premenopausal women. PMID: 27636223
    34. Genetic variation in COL1A1 and COL1A2 associated with osteogenesis imperfect in Vietnamese patients. PMID: 27519266
    35. 2 patients with osteogenesis imperfecta (father and daughter) had a previously undescribed c.3607C>T (p.Gln1203*) change in the COL1A1 gene. PMID: 27178384
    36. In the patient diagnosed with PCG and retinal detachment, analysis of WES data identified compound heterozygous variants in COL1A1 (p.Met264Leu; p.Ala1083Thr). PMID: 27484908
    37. These data, together with those available in literature, suggest that vascular events are not a diagnostic handle to differentiate patients with the p.(Arg312Cys) COL1A1 mutation from those with COL5A1 and COL5A2 defects, and highlight that during the diagnostic process the presence of at least the p.(Arg312Cys) substitution in COL1A1 should be investigated in cEDS patients without type V collagen mutations. PMID: 28102596
    38. we report an infant with severe OI born following a twin pregnancy in whom the bone disease is caused by a heterozygous pathogenic mutation, c.4160C >T, p.(Ala1387Val) located in the C-propeptide region of COL1A1. Our case adds to the growing evidence of the literature on mutations in the C-propeptide region being associated with a severe OI phenotype. PMID: 27549894
    39. We conducted a retrospective analysis of data from clinical, laboratory, and radiographic information from children evaluated for child abuse in which molecular testing for COL1A1 and COL1A2 genes was conducted. A total of 43 patients underwent molecular testing for Osteogenesis imperfecta (OI) PMID: 27090748
    40. our data revealed that COL1A1, UCP2, and PRPF40A are novel players implicated in the complex network of hypoxia response in non-small cell lung cancer PMID: 28258342
    41. In the individuals with a COL1A1 mutation, 70% (7/10) of those with a glycine substitution located C-terminal of p.Gly305 exhibited DGI in both dentitions while no individual (0/7) with a mutation N-terminal of this point exhibited DGI in either dentition PMID: 28498836
    42. Large COPII vesicles are transport carriers of intracellular carriers of procollagen I. PMID: 28428367
    43. we established a new regulatory model of COL1A1 regulation by HIF-1, and bring out its relationship with Sp3 transcription factor. In a fundamental level, these findings give insights in the mechanisms controlling COL1A1 gene expression. PMID: 27521280
    44. UBQLN4, APP, CTNNB1, SHBG, and COL1A1 might be involved in the development of nonalcoholic fatty liver disease, and are proposed as the potential markers for predicting the development of this condition PMID: 28796060
    45. The levels of the bone formation marker PICP in premenopausal rheumatoid arthritis women were significantly higher than in healthy premenopausal controls. There was a highly significant difference between postmenopausal patients with RA and control pre- and postmenopausal women. Furthermore, postmenopausal RA women had significantly higher plasma PICP concentrations than premenopausal women with RA PMID: 27775453
    46. Depletion of FKBP65 and inhibition of FKBP65 activity reduced the dimeric (active) form of LH2 but did not affect the binding of monomeric (inactive) LH2 to procollagen Ialpha1. PMID: 27298363
    47. This is the first study to quantitatively relate pressure-induced microstructural changes in resistance arteries to the mechanics of their wall. Principal findings using a pig model system were confirmed in human arteries. The combined methods provide a strong tool for future hypothesis-driven studies of microvascular pathologies. PMID: 28432057
    48. COL11A1 as a highly specific biomarker of activated cancer-associated fibroblasts in epithelial cancers. PMID: 27609069
    49. miR-29b can reduce collagen biosynthesis during skin wound healing likely via post-transcriptional inhibition of HSP47 expression. PMID: 27477081
    50. The study shows that circCOL3A1-859267 RNA regulate type I collagen expression in photoaged human dermal fibroblasts, suggesting it may be a novel target for interfering with photoaging. PMID: 28286269

    顯示更多

    收起更多

  • 相關疾病:
    Caffey disease (CAFFD); Ehlers-Danlos syndrome, classic type (EDS); Ehlers-Danlos syndrome 7A (EDS7A); Osteogenesis imperfecta 1 (OI1); Osteogenesis imperfecta 2 (OI2); Osteogenesis imperfecta 3 (OI3); Osteogenesis imperfecta 4 (OI4); Osteoporosis (OSTEOP)
  • 亞細胞定位:
    Secreted, extracellular space, extracellular matrix.
  • 蛋白家族:
    Fibrillar collagen family
  • 組織特異性:
    Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 2197

    OMIM: 114000

    KEGG: hsa:1277

    STRING: 9606.ENSP00000225964

    UniGene: Hs.172928



主站蜘蛛池模板: 久久精品a亚洲国产v高清不卡| 午夜影视啪啪免费体验区入口 | 性色欲情网站| 国产精品va尤物在线观看| 免费女人18毛片a毛片视频| 国产日产欧美最新| 无码人妻一区二区三区免费看成人| 亚洲国产精品无码一线岛国| 女人下面毛多水多视频| 日本免费一区二区三区日本| 688欧美人禽杂交狂配 | 后入到高潮免费观看| 亚洲日韩国产成网在线观看| 精品无人乱码一区二区三区的特点| 成人无码潮喷在线观看| 国产公开久久人人97超碰| 午夜福利伦伦电影理论片在线观看| 国产熟女一区二区三区四区五区| 成人乱人伦视频在线观看| 天堂网www在线资源最新版| 2021国产成人精品久久| 国产猛烈高潮尖叫视频免费| 亚洲va欧美va天堂v国产综合| 亚洲337少妇裸体艺术| 日本vs亚洲vs韩国一区三区| 国产午夜福利伦理300| 大地资源中文第三页| 免费观看又色又爽又黄的崩锅| 午夜成人爽爽爽视频在线观看| 国产三级精品三级在线专1| 日本污ww视频网站| 国产成人一区二区三区影院动漫| 久久香蕉超碰97国产精品| 亚洲免费网站观看视频| 国产末成年女av片一区二区| 国产精品久久久影视青草| 国产性猛交普通话对白| 97色伦97色伦国产欧美| 中文字幕人乱码中文| 大学生高潮无套内谢视频| 亚洲高清专区日韩精品|